Hypolipidaemic effects of high-dose insulin therapy

British Journal of Anaesthesia

Volumn 100, Issue 4, 2008, Pages 429-433

  Evans, R D ^a   Niu, Y ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID;

ACUTE HEART INFARCTION; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; FATTY ACID BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HORMONE RELEASE; HUMAN; HYPOLIPEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; LIPID METABOLISM; PRIORITY JOURNAL; REPERFUSION INJURY; BLOOD; CHEMICALLY INDUCED DISORDER; DYSLIPIDEMIA; METHODOLOGY; NOTE; PERIOPERATIVE PERIOD;

CARDIAC SURGICAL PROCEDURES; DYSLIPIDEMIAS; HUMANS; INSULIN; LIPID METABOLISM; LIPIDS; PERIOPERATIVE CARE;

EID: 41949124044     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen027     Document Type: Editorial

References (33)

1. Zuurbier CJ, Hoek FJ, van Dijk J, et al. Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth 2008; 100: 442-50
2. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27: 2716-24
3. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU [see comment]. N Engl J Med 2006; 354: 449-61
4. Bothe W, Olschewski M, Beyersdorf F, Doenst T. Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg 2004; 78: 1650-7
5. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000; 70: 145-50
6. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227-34
7. Bruemmer-Smith S, Avidan MS, Harris B, et al. Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth 2002; 88: 489-95
8. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE, Jr, Kirklin JK, Stanley AW, Jr Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg 2002; 73: 1246-51; discussion 51-2
9. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999; 13: 191-200
10. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-46
11. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg 2003; 75: S721-8
12. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55: 3151-9
13. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146: 233-43
14. Lopaschuk GD. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Coron Artery Dis 2001; 12 (Suppl 1): S8-11
15. Hauton D, Bennett MJ, Evans RD. Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim Biophys Acta 2001; 1533: 99-109
16. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5′-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 2006; 99: 61-8
17. Taegtmeyer H. Glucose for the heart: too much of a good thing? J Am Coll Cardiol 2005; 46: 49-50
18. Szabo Z, Arnqvist H, Hakanson E, Jorfeldt L, Svedjeholm R. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with type II diabetes. Clin Sci 2001; 101: 37-43
19. Stanley AW, Jr, Moraski RE, Russell RO, et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol 1975; 36: 929-37
20. Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 2003; 284: E331-9
21. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004; 109: 2191-6
22. Tuunanen H, Engblom E, Naum A, et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure [see comment]. Circulation 2006; 114: 2130-7
23. Wiggers H, Norrelund H, Nielsen SS, et al. Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol 2005; 289: H938-46
24. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-7
25. Heather LC, Cole MA, Lygate CA, et al. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc Res 2006; 72: 430-7
26. King LM, Sidell RJ, Wilding JR, Radda GK, Clarke K. Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. Am J Physiol Heart Circ Physiol 2001; 280: H1173-81
27. Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2005; 288: H2102-10
28. Augustus AS, Buchanan J, Park TS, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006; 281: 8716-23
29. Noh HL, Okajima K, Molkentin JD, Homma S, Goldberg IJ. Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. Am J Physiol Endocrinol Metab 2006; 291: E755-60
30. Niu YG, Hauton D, Evans RD. Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates. J Physiol 2004; 558: 225-37
31. Golfman LS, Wilson CR, Sharma S, et al. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 2005; 289: E328-36
32. van Wezel HB, Zuurbier CJ, de Jonge E, et al. Differential effects of a perioperative hyperinsulinemic normoglycemic clamp on the neurohumoral stress response during coronary artery surgery. J Clin Endocrinol Metab 2006; 91: 4144-53
33. Visser L, Zuurbier CJ, Hoek FJ, et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 2005; 95: 448-57